PP1 has been implicated with AD in several aspects, including tau protein phosphorylation, amyloid precursor protein (APP) processing, synaptic dysfunction, neuronal survival, and therapeutic targeting, respectively [40]. Here, MAPT is linked to Alzheimer disease.